10-K: Myriad Genetics Inks 15-Year Lease for New Salt Lake City Facility, Secures Expansion Options
Commercial Lease Agreement
Myriad Genetics has entered into a 15-year lease agreement for a new facility in Salt Lake City, with options for expansion and early termination under specific conditions.
Summary
- Myriad Genetics has signed a 15-year lease for a 231,841 square foot facility in Salt Lake City, with phased delivery of the premises.
- The lease includes options for lease extensions and rights of first refusal and first offer on additional space in the building and park.
- The initial annual rent is $4,128,637.50, with monthly installments of $344,053.13, subject to a six-month abatement.
- Rent will increase by 2.5% annually, with adjustments for additional space.
- The lease is a net lease, with Tenant responsible for certain operating costs and reimbursements to Landlord.
- Tenant will receive a tenant improvement allowance of $85 per rentable square foot and an HVAC allowance of $15 per rentable square foot.
- The lease includes a termination right for Tenant if the Phase I premises are not delivered by November 15, 2022.
- The lease provides for a total of 3.46 parking spaces per 1,000 RSF, with additional exclusive parking in the fenced yard.
- The lease includes provisions for maintenance, repairs, alterations, insurance, indemnity, and handling of hazardous materials.
Sentiment
Score: 7
Explanation: The document is a standard commercial lease agreement, which is generally positive for the company's growth prospects. The terms are reasonable and provide flexibility for the company.
Positives
- The lease provides Myriad Genetics with a large, modern facility to support its operations.
- The tenant improvement and HVAC allowances will help offset the costs of customizing the space.
- The lease includes options for future expansion, providing flexibility for growth.
- The parking provisions are generous, ensuring adequate parking for employees and visitors.
- The lease includes a termination right for Tenant if the Phase I premises are not delivered by November 15, 2022, providing some protection against delays.
Negatives
- The lease is a net lease, meaning Tenant is responsible for many operating costs.
- The rent increases by 2.5% annually, which could increase costs over time.
- The lease includes a management fee equal to two percent (2%) of the Monthly Basic Rent.
Risks
- Delays in the delivery of the premises could trigger the termination clause.
- Tenant is responsible for a significant portion of the operating costs, which could fluctuate.
- The lease includes a management fee equal to two percent (2%) of the Monthly Basic Rent.
- The lease includes a termination right for Tenant if the Phase I premises are not delivered by November 15, 2022.
Future Outlook
The lease includes options for lease extensions and rights of first refusal and first offer on additional space, providing flexibility for future growth. The lease also includes a termination right for Tenant if the Phase I premises are not delivered by November 15, 2022.
Industry Context
This lease agreement reflects a trend in the life sciences industry towards securing modern, flexible facilities to support research and development activities. The inclusion of expansion options and a termination clause provides Myriad with flexibility to adapt to changing market conditions.
Comparison to Industry Standards
- The lease terms, including the tenant improvement allowance and rent escalations, appear to be consistent with industry standards for life science properties in the Salt Lake City area.
- The inclusion of options for lease extensions and rights of first refusal and first offer are common in leases for growing companies.
- The parking provisions are generous, which is important for a facility of this size.
- The lease is a net lease, which is typical for commercial properties of this type.
Stakeholder Impact
- Shareholders will view this lease as a positive step for the company's growth.
- Employees will benefit from a modern, well-equipped facility.
- Customers will benefit from the company's ability to provide high-quality testing services.
- Suppliers will benefit from the company's continued operations.
Next Steps
- Lessor will deliver the Premises to Lessee in phases.
- Lessor will measure all phases of the Premises no later than 30 days after the Phase IV Possession Date.
- Lessor and Lessee will enter into an amendment to the Lease stating the Confirmed Rentable Area.
- Lessee will begin paying Monthly Basic Rent seven months after the Commencement Date.
Key Dates
| Date | Description |
|---|---|
| December 1, 1998 | Date of Declaration of Covenants, Conditions and Restrictions and Reciprocal Easements recorded in the public records of Salt Lake County, Utah. |
| October 22, 2013 | Date of Amendment No. 1 to Declaration of Covenants, Conditions and Restrictions and Reciprocal Easements recorded in the public records of Salt Lake County, Utah. |
| February 20, 2019 | Date of Amendment No. 2 to Declaration of Covenants, Conditions and Restrictions and Reciprocal Easements recorded in the public records of Salt Lake County, Utah. |
| November 15, 2022 | Deadline for Lessor to deliver Phase I Premises in Space Delivery Condition, after which Tenant may elect to terminate the lease. |
| August 1, 2023 | Currently anticipated date for the Commencement Date of the Lease. |
| August 1, 2026 | Currently anticipated date for the Phase V Lease Commencement Date. |
Keywords
lease, Myriad Genetics, Salt Lake City, tenant improvement allowance, HVAC allowance, rent, commercial real estate, office space, laboratory space, parking, lease extension, right of first refusal, right of first offer, hazardous materials, net lease
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.